ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATE Antibe Therapeutics Inc

0.295
0.00 (0.00%)
Last Updated: 09:21:54
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End March 30 2023 20162017201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 9.74M10.73M12.49M14.82M13.84M81.74M89.16M70.56M
Total Current Assets 5.01M6.22M8.31M10.56M11.51M79.1M61.36M41.55M
Cash and Equivalents 386k1.5M3.73M5.99M6.18M71.97M34.81M6.76M
Total Non-Current Assets 4.71M3.55M7.98M7.44M3.78M50.26M56.83M40.17M
Total Liabilities 5.03M7.17M4.52M7.38M10.06M31.48M32.33M30.4M
Total Current Liabilities 3.01M3.15M3.43M2.91M7.6M3.74M4.69M2.76M
Total Non-Current Liabilities 4.05M6.66M1.08M6.54M2.46M27.84M27.63M27.63M
Total Equity 4.71M3.55M7.98M7.44M3.78M50.26M56.83M40.17M
Common Equity 15.2M19.25M30.01M39.74M52.29M121.93M149.81M151.75M
Retained Earnings -13.61M-20.06M-27.51M-40.34M-59.67M-85.96M-111.02M-130.49M

Your Recent History

Delayed Upgrade Clock